DNA insider transaction filings

Ginkgo Bioworks Holdings, Inc. — 42 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-30. Screen DNA transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-304Canton Barry — 10% ownerGrant/award (A): 35,736 (derivative) · Grant/award (A): 117,135 (derivative) · Grant/award (A): 39,038 (derivative) · Grant/award (A): 127,423 (derivative)EDGAR
2026-07-304Shetty Reshma P. — See remarks, Director, 10% ownerGrant/award (A): 39,038 (derivative) · Grant/award (A): 127,423 (derivative) · Grant/award (A): 35,736 (derivative) · Grant/award (A): 117,135 (derivative)EDGAR
2026-07-304Kelly Jason R — See remarks, DirectorGrant/award (A): 74,258 (derivative) · Grant/award (A): 309,467 (derivative)EDGAR
2026-07-204Coen Steven P. — See remarksOption exercise (M): 1,174 · Option exercise (M): 312 · Sale (S): 752 @ $7.90 · Option exercise (M): 1,174 (derivative) · Option exercise (M): 312 (derivative)EDGAR
2026-06-154Fubini Ross — DirectorGrant/award (A): 25,000 (derivative)EDGAR
2026-06-154Kosuri Sri — DirectorGrant/award (A): 25,000 (derivative)EDGAR
2026-06-154HENRY CHRISTIAN O — DirectorGrant/award (A): 25,000 (derivative)EDGAR
2026-06-154SLOAN HARRY — DirectorGrant/award (A): 25,000 (derivative)EDGAR
2026-05-264Coen Steven P. — See remarksOption exercise (M): 587 · Option exercise (M): 156 · Sale (S): 307 @ $8.33 · Option exercise (M): 587 (derivative) · Option exercise (M): 156 (derivative)EDGAR
2026-04-204Coen Steven P. — See remarksOption exercise (M): 587 · Option exercise (M): 156 · Sale (S): 324 @ $7.95 · Option exercise (M): 587 (derivative) · Option exercise (M): 156 (derivative)EDGAR
2026-04-144Coen Steven P. — See remarksOption exercise (M): 28,368 · Option exercise (M): 45,553 · Sale (S): 33,171 @ $6.41 · Option exercise (M): 28,368 (derivative) · Option exercise (M): 45,553 (derivative)EDGAR
2026-04-134Canton Barry — 10% ownerOption exercise (M): 251,786 · Sale (S): 124,727 @ $6.43 · Option exercise (M): 251,786 (derivative)EDGAR
2026-04-134Shetty Reshma P. — See remarks, Director, 10% ownerOption exercise (M): 251,786 · Sale (S): 124,727 @ $6.43 · Option exercise (M): 251,786 (derivative)EDGAR
2026-04-104Shetty Reshma P. — See remarks, Director, 10% ownerOption exercise (M): 27,738 · Option exercise (M): 27,738 · Sale (S): 13,155 @ $6.93 · Sale (S): 13,116 @ $6.40 · Option exercise (M): 27,738 (derivative) · Option exercise (M): 27,738 (derivative)EDGAR
2026-04-104Canton Barry — 10% ownerOption exercise (M): 27,738 · Option exercise (M): 27,738 · Sale (S): 13,155 @ $6.93 · Sale (S): 13,116 @ $6.40 · Option exercise (M): 27,738 (derivative) · Option exercise (M): 27,738 (derivative)EDGAR
2026-04-104Kelly Jason R — See remarks, DirectorOption exercise (M): 212,949 · Option exercise (M): 212,949 · Sale (S): 97,015 @ $6.93 · Sale (S): 109,767 @ $6.40 · Option exercise (M): 212,949 (derivative) · Option exercise (M): 212,949 (derivative)EDGAR
2026-03-184Coen Steven P. — See remarksOption exercise (M): 1,174 · Option exercise (M): 312 · Sale (S): 708 @ $6.74 · Option exercise (M): 1,174 (derivative) · Option exercise (M): 312 (derivative)EDGAR
2026-01-224Coen Steven P. — See remarksOption exercise (M): 587 · Option exercise (M): 156 · Option exercise (M): 1,062 · Sale (S): 972 @ $8.92 · Option exercise (M): 587 (derivative) · Option exercise (M): 156 (derivative) · +1 moreEDGAR
2025-12-164Coen Steven P. — See remarksOption exercise (M): 1,174 · Option exercise (M): 312 · Sale (S): 736 @ $8.89 · Option exercise (M): 1,174 (derivative) · Option exercise (M): 312 (derivative)EDGAR
2025-10-214Coen Steven P. — See remarksOption exercise (M): 1,174 · Option exercise (M): 312 · Option exercise (M): 1,061 · Sale (S): 1,312 @ $13.65 · Option exercise (M): 1,174 (derivative) · Option exercise (M): 312 (derivative) · +1 moreEDGAR
2025-10-034Coen Steven P. — See remarksSale (S): 5,609 @ $15EDGAR
2025-09-104HENRY CHRISTIAN O — DirectorSale (S): 10,000 @ $10.92 · Sale (S): 10,000 @ $11.06EDGAR
2025-08-264Coen Steven P. — See remarksOption exercise (M): 587 · Option exercise (M): 156 · Sale (S): 310 @ $12.40 · Option exercise (M): 587 (derivative) · Option exercise (M): 156 (derivative)EDGAR
2025-07-214Coen Steven P. — See remarksOption exercise (M): 1,174 · Option exercise (M): 312 · Option exercise (M): 1,061 · Sale (S): 1,084 @ $9.84 · Option exercise (M): 1,174 (derivative) · Option exercise (M): 312 (derivative) · +1 moreEDGAR
2025-06-134Kosuri Sri — DirectorOption exercise (M): 24,067 · Option exercise (M): 24,067 (derivative) · Grant/award (A): 34,375 (derivative) @ $0EDGAR
2025-06-134Fubini Ross — DirectorOption exercise (M): 10,822 · Option exercise (M): 10,822 (derivative) · Grant/award (A): 34,375 (derivative) @ $0EDGAR
2025-06-134Sankar Shyam — DirectorOption exercise (M): 10,822 · Option exercise (M): 10,822 (derivative) · Grant/award (A): 34,375 (derivative) @ $0EDGAR
2025-06-134Hannan Kathy Hopinkah — DirectorOption exercise (M): 10,822 · Option exercise (M): 10,822 (derivative)EDGAR
2025-06-134HENRY CHRISTIAN O — DirectorOption exercise (M): 10,822 · Option exercise (M): 10,822 (derivative) · Grant/award (A): 34,375 (derivative) @ $0EDGAR
2025-06-134SLOAN HARRY — DirectorOption exercise (M): 10,822 · Option exercise (M): 10,822 (derivative) · Grant/award (A): 34,375 (derivative) @ $0EDGAR
2025-06-134POTTER MYRTLE S — DirectorOption exercise (M): 10,822 · Option exercise (M): 10,822 (derivative)EDGAR
2025-05-224Coen Steven P. — See remarksOption exercise (M): 587 · Option exercise (M): 156 · Sale (S): 346 @ $7.58 · Option exercise (M): 587 (derivative) · Option exercise (M): 156 (derivative)EDGAR
2025-05-224Dmytruk Mark E. — See remarksOption exercise (M): 454 · Option exercise (M): 453 · Option exercise (M): 572 · Sale (S): 706 @ $7.58 · Option exercise (M): 454 (derivative) · Option exercise (M): 453 (derivative) · +1 moreEDGAR
2025-04-234Coen Steven P. — See remarksOption exercise (M): 587 · Option exercise (M): 156 · Option exercise (M): 1,061 · Sale (S): 997 @ $7.28 · Option exercise (M): 587 (derivative) · Option exercise (M): 156 (derivative) · +1 moreEDGAR
2025-04-234Dmytruk Mark E. — See remarksOption exercise (M): 454 · Option exercise (M): 453 · Option exercise (M): 572 · Option exercise (M): 1,061 · Option exercise (M): 8 · Sale (S): 1,244 @ $7.28 · +5 moreEDGAR
2025-03-174Dmytruk Mark E. — See remarksConversion (C): 9,497 @ $0 · Conversion (C): 9,497 (derivative) @ $0EDGAR
2025-03-104Coen Steven P. — See remarksGrant/award (A): 4,245 (derivative)EDGAR
2025-03-104Dmytruk Mark E. — See remarksGrant/award (A): 4,245 (derivative)EDGAR
2025-03-064Coen Steven P. — See remarksOption exercise (M): 587 · Option exercise (M): 156 · Sale (S): 395 @ $7.72 · Option exercise (M): 587 (derivative) · Option exercise (M): 156 (derivative)EDGAR
2025-03-064Dmytruk Mark E. — See remarksOption exercise (M): 454 · Option exercise (M): 453 · Option exercise (M): 572 · Sale (S): 790 @ $7.72 · Option exercise (M): 454 (derivative) · Option exercise (M): 453 (derivative) · +1 moreEDGAR
2025-02-064Coen Steven P. — See remarksOption exercise (M): 587 · Option exercise (M): 156 · Sale (S): 367 @ $13.44 · Option exercise (M): 587 (derivative) · Option exercise (M): 156 (derivative)EDGAR
2025-02-064Dmytruk Mark E. — See remarksOption exercise (M): 454 · Option exercise (M): 453 · Option exercise (M): 572 · Option exercise (M): 8 · Sale (S): 740 @ $13.44 · Option exercise (M): 454 (derivative) · +3 moreEDGAR

Recent 8-K events — Ginkgo Bioworks Holdings, Inc.

FiledFormItems reportedSource
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-308-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-128-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-078-K2.01 — Completion of Acquisition or Disposition of Assets
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-278-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-268-K2.02 — Results of Operations and Financial ConditionEDGAR
2025-12-238-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
EDGAR
2025-11-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-09-048-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=DNA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →